Algert Global LLC Acquires 59,850 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Algert Global LLC boosted its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 521.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 71,335 shares of the company's stock after purchasing an additional 59,850 shares during the quarter. Algert Global LLC owned about 0.18% of Phibro Animal Health worth $1,606,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Jacobs Levy Equity Management Inc. lifted its holdings in shares of Phibro Animal Health by 56.0% in the first quarter. Jacobs Levy Equity Management Inc. now owns 79,667 shares of the company's stock valued at $1,030,000 after purchasing an additional 28,584 shares in the last quarter. Sofinnova Investments Inc. purchased a new stake in shares of Phibro Animal Health during the 2nd quarter valued at $3,975,000. Acadian Asset Management LLC raised its stake in shares of Phibro Animal Health by 6.3% during the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company's stock worth $12,027,000 after purchasing an additional 42,299 shares during the period. nVerses Capital LLC purchased a new position in shares of Phibro Animal Health in the 3rd quarter worth about $70,000. Finally, Dana Investment Advisors Inc. grew its position in Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company's stock valued at $8,619,000 after buying an additional 75,546 shares during the period. Institutional investors own 99.34% of the company's stock.

Analysts Set New Price Targets

PAHC has been the topic of a number of research analyst reports. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 target price on the stock. StockNews.com upgraded Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a research note on Thursday. Barclays lifted their target price on Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a report on Tuesday, November 12th. Finally, Bank of America increased their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a report on Friday, August 30th. Three investment analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of "Hold" and an average target price of $16.50.

Insider Buying and Selling

In other news, Director E Thomas Corcoran acquired 5,000 shares of the business's stock in a transaction dated Wednesday, September 4th. The stock was purchased at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the acquisition, the director now owns 25,000 shares of the company's stock, valued at $500,500. This trade represents a 25.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 50.07% of the stock is owned by company insiders.

Phibro Animal Health Price Performance

Phibro Animal Health stock traded down $0.02 during midday trading on Thursday, hitting $23.59. 99,234 shares of the company's stock were exchanged, compared to its average volume of 158,638. The stock has a 50-day moving average price of $23.27 and a two-hundred day moving average price of $20.14. Phibro Animal Health Co. has a 52-week low of $9.49 and a 52-week high of $25.98. The company has a market cap of $955.40 million, a P/E ratio of 54.86, a PEG ratio of 0.62 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.34 by $0.07. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. The company had revenue of $273.16 million for the quarter, compared to analysts' expectations of $262.44 million. On average, equities research analysts forecast that Phibro Animal Health Co. will post 1.61 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be given a $0.12 dividend. The ex-dividend date is Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.03%. Phibro Animal Health's dividend payout ratio (DPR) is presently 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.